Bibliographic citations
This is an automatically generated citacion. Modify it if you see fit
Prada, M., (2024). Revisión crítica: efecto del consumo de ácidos grasos en la prevención de enfermedades cardiovasculares [Universidad Privada Norbert Wiener]. https://hdl.handle.net/20.500.13053/12464
Prada, M., Revisión crítica: efecto del consumo de ácidos grasos en la prevención de enfermedades cardiovasculares []. PE: Universidad Privada Norbert Wiener; 2024. https://hdl.handle.net/20.500.13053/12464
@misc{renati/1379411,
title = "Revisión crítica: efecto del consumo de ácidos grasos en la prevención de enfermedades cardiovasculares",
author = "Prada Coello, Melissa Consuelo",
publisher = "Universidad Privada Norbert Wiener",
year = "2024"
}
Title: Revisión crítica: efecto del consumo de ácidos grasos en la prevención de enfermedades cardiovasculares
Other Titles: Critical review: effect of probiotics for improving intestinal motility in adults suffering from constipation
Authors(s): Prada Coello, Melissa Consuelo
Advisor(s): Bohórquez Medina, Andrea Lisbet
Keywords: Ácidos Grasos Omega-3; Enfermedades Cardiovasculares; Suplementos Dietéticos; Fatty Acids, Omega-3; Cardiovascular Diseases; Dietary Supplements
OCDE field: https://purl.org/pe-repo/ocde/ford#3.03.04; https://purl.org/pe-repo/ocde/ford#3.02.21; https://purl.org/pe-repo/ocde/ford#3.02.04
Issue Date: 13-Nov-2024
Institution: Universidad Privada Norbert Wiener
Abstract: Las patologías cardiovasculares son fallas del corazón y de los vasos sanguíneos, lo
cual puede desencadenar la muerte del paciente, debido al infarto de miocardio. Se
ha evidenciado que los ω-3, disminuyen la exposición de enfermedades
cardiovasculares (cardiopatías coronarias, infarto de miocardio) y no en accidentes
cerebrovasculares. El presente trabajo investigativo de nivel secundario tuvo por
objetivo fue determinar el impacto de la ingesta de suplementos ω-3, en la
precaución de exposición de ECV. Se realizó mediante la estrategia de trabajo de
Nutrición Basada en Evidencia (Nube). Los bancos de datos, utilizados en la
indagación sistemática, fueron: SCOPUS, Pubmed y Dialnet; se hallaron 11
estudios, de los cuales se seleccionaron los 11, donde se utilizó el instrumento
CASPE, para el juicio de la lección, se eligió el Ensayo Clínico Aleatorizado con
título; Suplementos marinos de ω-3 y enfermedades cardiovasculares: Un
metaanálisis actualizado de 13 ensayos controlados aleatorios con 127 477
participantes, el mismo que tiene un nivel I, tanto para la evidencia como para la
categoría de sugerencia, de acuerdo a la competencia del experto. Se puede
concluir a partir del comentario critico que una dosis de 1000mg/d de ω-3 marino,
fomenta a la mermar la exposición de desarrollar ECV.
Cardiovascular pathologies are failures of the heart and blood vessels, which can lead to the patient's death due to myocardial infarction. It has been evidenced that ω3 fatty acids reduce the exposure to cardiovascular diseases (coronary heart disease, myocardial infarction) but not to cerebrovascular accidents. The objective of this secondary level research work was to determine the impact of ω-3 supplement intake on the prevention of exposure to cardiovascular diseases (CVD). This was carried out using the Evidence-Based Nutrition (Nube) work strategy. The databases used in the systematic inquiry were: SCOPUS, Pubmed, and Dialnet; 11 studies were found, all of which were selected. The CASPE instrument was used for the judgment of the selection, and the Randomized Clinical Trial titled "Marine ω-3 Supplements and Cardiovascular Diseases: An Updated Meta-Analysis of 13 Randomized Controlled Trials with 127,477 Participants" was chosen, which has a level I rating for both evidence and suggestion category, according to expert competence. It can be concluded from the critical commentary that a dose of 1000 mg/day of marine ω-3 promotes a reduction in the exposure to developing cardiovascular diseases.
Cardiovascular pathologies are failures of the heart and blood vessels, which can lead to the patient's death due to myocardial infarction. It has been evidenced that ω3 fatty acids reduce the exposure to cardiovascular diseases (coronary heart disease, myocardial infarction) but not to cerebrovascular accidents. The objective of this secondary level research work was to determine the impact of ω-3 supplement intake on the prevention of exposure to cardiovascular diseases (CVD). This was carried out using the Evidence-Based Nutrition (Nube) work strategy. The databases used in the systematic inquiry were: SCOPUS, Pubmed, and Dialnet; 11 studies were found, all of which were selected. The CASPE instrument was used for the judgment of the selection, and the Randomized Clinical Trial titled "Marine ω-3 Supplements and Cardiovascular Diseases: An Updated Meta-Analysis of 13 Randomized Controlled Trials with 127,477 Participants" was chosen, which has a level I rating for both evidence and suggestion category, according to expert competence. It can be concluded from the critical commentary that a dose of 1000 mg/day of marine ω-3 promotes a reduction in the exposure to developing cardiovascular diseases.
Link to repository: https://hdl.handle.net/20.500.13053/12464
Discipline: Segunda Especialidad en Nutrición Clínica con mención en Nutrición Oncológica
Grade or title grantor: Universidad Privada Norbert Wiener. Facultad de Ciencias de la Salud
Grade or title: Especialista en Nutrición Clínica con mención en Nutrición Oncológica
Juror: Mauricio Alza, Saby Marisol; Pasache Moreno, Julissa María; León Cáceres, Johanna Del Carmen
Register date: 27-Dec-2024
This item is licensed under a Creative Commons License